MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjmed.2014.10.034

Медицинская библиотека · The American journal of medicine · 2014

Effectiveness of inferior vena cava filters on mortality as an adjuvant to antithrombotic therapy.

Isogai Toshiaki, Yasunaga Hideo, Matsui Hiroki, Tanaka Hiroyuki, Horiguchi Hiromasa, Fushimi Kiyohide

Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Despite growing evidence of complications, inferior vena cava filters are being used increasingly in patients with venous thromboembolism based on limited efficacy data. In such a controversial situation, the effectiveness of filter use on mortality as an adjuvant to antithrombotic therapy for pulmonary embolism remains uncertain.

METHODS

Using the Diagnosis Procedure Combination database in Japan, we identified patients hospitalized with pulmonary embolism who received anticoagulation or thrombolytic therapy from the day of admission. We compared the in-hospital mortality between patients who received a filter and patients who did not, using propensity score and instrumental variable methods.

RESULTS

Of 13,125 eligible patients, 3948 received a filter, and 9177 did not receive a filter. The propensity score-matched analysis showed that filter use was significantly associated with lower in-hospital mortality than nonuse (2.6% vs 4.7%, P < .001; risk ratio 0.55; 95% confidence interval [CI], 0.43-0.71; risk difference -2.1%; 95% CI, -3.0% to -1.2%; number needed to treat, 48; 95% CI, 34-82). We obtained similar results in the inverse probability of treatment-weighting analysis. The instrumental variable analysis confirmed that filter use was associated with a decreased risk of in-hospital mortality with adjustment for all measured variables (risk difference -2.5%, 95% CI, -4.6% to -0.4%).

CONCLUSIONS

This study suggested that filter use was potentially effective for reducing in-hospital mortality in patients with pulmonary embolism. Prospective studies are needed to confirm the effectiveness observed in our results and to define which subpopulations of patients would benefit most from filters.

Для цитирования: Isogai Toshiaki, Yasunaga Hideo, Matsui Hiroki, Tanaka Hiroyuki, Horiguchi Hiromasa, Fushimi Kiyohide. Effectiveness of inferior vena cava filters on mortality as an adjuvant to antithrombotic therapy.. The American journal of medicine. 2014. DOI: 10.1016/j.amjmed.2014.10.034.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.